Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
ACS Medicinal Chemistry Letters2010Vol. 1(7), pp. 331–335
Citations Over TimeTop 10% of 2010 papers
Ryan C. Murphy, Kayode K. Ojo, E.T. Larson, Alejandro Castellanos-González, B. Gayani K. Perera, Katelyn R. Keyloun, Jessica E. Kim, Janhavi Bhandari, Natascha R. Muller, Christophe L. M. J. Verlinde, A. Clinton White, E.A. Merritt, Wesley C. Van Voorhis, Dustin J. Maly
Abstract
The protozoans Cryptosporidium parvum and Toxoplasma gondii are parasites of major health concern to humans. Both parasites contain a group of calcium-dependent protein kinases (CDPKs), which are found in plants and ciliates but not in humans or fungi. Here we describe a series of potent inhibitors that target CDPK1 in C. parvum (CpCDPK1) and T. gondii (TgCDPK1). These inhibitors are highly selective for CpCDPK1 and TgCDPK1 over the mammalian kinases SRC and ABL. Furthermore, they are able to block an early stage of C. parvum invasion of HCT-8 host cells, which is similar to their effects on T. gondii invasion of human fibroblasts.
Related Papers
- → Boromycin Has Potent Anti-Toxoplasmaand Anti-CryptosporidiumActivity(2021)17 cited
- → A simple and reliable method of producing in vitro infections ofcryptosporidium parvum(apicomplexa)(1994)100 cited
- → A simple and reliable method of producing in vitro infections of cryptosporidium parvum (apicomplexa)(1994)11 cited
- Alteration of Cryptosporidium parvum (Apicomplexa: Eucoccidiorida) Oocyst Antigens Following Bleach Treatment(2001)
- → S3.12 The ADP/ATP carrier of the apicomplexa Cryptosporidium parvum(2008)